Patent · US Expired

Phenylalanine enamide derivatives

US6878718B2 · kind B2 · utility

7Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2002
Grant dateApr 12, 2005
Priority date
Expiry dateSep 18, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/96
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Phenylalanine enamide derivatives of formula (1) are described: wherein The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.